Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY 4.0Bone Reports

Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study

  • Syeda Masooma Naqvi
  • Wahaaj Ali
  • Hollie Allison
  • Laura O'Sullivan
  • Gill Holdsworth
  • Juan Alberto Panadero-Perez
  • Jessica Schiavi-Tritz
  • Laoise McNamara
Open at sourcePDFDOICite

Related

  1. Clinical outcomes following five-day accelerated intermittent theta burst stimulation for treatment-resistant depression in routine clinical practice: A prospective naturalistic cohort study
    Asmi Khanna, Adrian Espiritu, Lynn Zhu +7
    CNS SpectrumsPeer-reviewedCC BY 4.0Full textNeurologyPMC
  2. Osteoporosis and Alzheimer's Disease: The Role of Sclerostin.
    Lorelé Gagiano, Ziming Chen, William G Blakeney +4
    Current osteoporosis reportsPeer-reviewedCC BYFull textPhysiologyEurope PMC
  3. Factors associated with the optimal uptake of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine: The experiences of postpartum women attending child welfare clinics in three rural districts in the Western Region of Ghana
    Gifty Amugi, Daniel Tetteh Agudey, Nana Mireku Gyimah +6
    PLOS OnePeer-reviewedCC BY 4.0Full textGeneral biologyGeology & geochemistryPLOSPMC
  4. Sclerostin downregulation in aseptic loosening
    Assil-Ramin Alimy, Eva Goedecke, Ana Ocokoljic +3
    Bone & joint researchPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCEurope PMCPMC
  5. Multi-omics analysis explores the potential mechanisms of Huangtcia renifolia ethanolic extract against osteoporosis in ovariectomized rats
    Liping Yang, Tian Xiao, Zhuo Zhang +1
    Frontiers in endocrinologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{naqvi2026early,
  title = {{Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study}},
  author = {Syeda Masooma Naqvi and Wahaaj Ali and Hollie Allison and Laura O'Sullivan and Gill Holdsworth and Juan Alberto Panadero-Perez and Jessica Schiavi-Tritz and Laoise McNamara},
  journal = {Bone Reports},
  year = {2026},
  month = oct,
  doi = {10.1016/j.bonr.2026.101915},
  url = {https://univ-reims.hal.science/hal-05785469v1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study
AU  - Syeda Masooma Naqvi
AU  - Wahaaj Ali
AU  - Hollie Allison
AU  - Laura O'Sullivan
AU  - Gill Holdsworth
AU  - Juan Alberto Panadero-Perez
AU  - Jessica Schiavi-Tritz
AU  - Laoise McNamara
PY  - 2026
DA  - 2026/10/29
JO  - Bone Reports
DO  - 10.1016/j.bonr.2026.101915
UR  - https://univ-reims.hal.science/hal-05785469v1
SN  - 2352-1872
ER  -